Pradaxa 75mg Recall: Defective Bottles May Impair Drug Quality
Boehringer Ingelheim recalls specific lots of Pradaxa 75 mg capsules due to defective containers that may allow moisture damage. Check your bottle details.
Use caution until it’s fixed
Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
Contact the company
What happened, in plain English
Boehringer Ingelheim Roxane Inc is recalling specific bottles of Pradaxa (dabigatran etexilate) 75 mg capsules because the containers are defective. This defect could allow moisture to enter the bottle, potentially impairing the quality of the medication. The recall affects 8,381 bottles distributed nationwide. Read more at govinfonow.com/recall/48492-boehringer-ingelheim-roxane-inc-recalls-pradaxa-dabigatran-etexilate-75-mg.
Source Summary by GovInfoNow · govinfonow.com/recall/48492-boehringer-ingelheim-roxane-inc-recalls-pradaxa-dabigatran-etexilate-75-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-067-2013
Cite this page
“Pradaxa 75mg Recall: Defective Bottles May Impair Drug Quality.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48492-boehringer-ingelheim-roxane-inc-recalls-pradaxa-dabigatran-etexilate-75-mg. Based on FDA recall #D-067-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-067-2013%22&limit=1).
Why it’s dangerous
The defective containers may allow moisture to penetrate the bottle. This exposure to moisture can impair the quality of the product, potentially affecting its efficacy or safety profile.
Who’s affected
Patients who have been prescribed Pradaxa 75 mg capsules and possess bottles with the specific National Drug Code (NDC) and lot number listed in the record. The risk is limited to those holding the affected inventory.
How to tell if you have this one
Check your medication bottle for NDC 0597-0149-54 and Lot number 201900. The bottles contain 60 capsules each and were distributed by Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT.
- Brand
Pradaxa- Category
Drug
What to do — step by step
Check your bottle details
Verify if your Pradaxa bottle has NDC 0597-0149-54 and Lot 201900.
Contact your pharmacist or doctor
The record does not specify a remedy, so consult your healthcare provider for guidance on what to do with the affected medication.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 10 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
How many bottles are affected?
Approximately 8,381 bottles are included in this recall.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-067-2013 (November 5, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-067-2013 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.